-
1
-
-
0026761832
-
Low molecular weight heparin in prevention of perioperative thrombosis
-
Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. B M J 1992; 305: 913-20.
-
(1992)
B M J
, vol.305
, pp. 913-920
-
-
Leizorovicz, A.1
Haugh, M.C.2
Chapuis, F.R.3
Samama, M.M.4
Boissel, J.P.5
-
2
-
-
8544283873
-
Medical patients
-
Bergqvist D, Comeroca AJ, Nicolaides AN, Scurr JM (eds). London: Med-Orion
-
Clement DI, Gheeraaerr P, De Buyzere M, Duproz M. Medical patients. In: Bergqvist D, Comeroca AJ, Nicolaides AN, Scurr JM (eds). Prevention of venous thromboembolism. London: Med-Orion; 1994; 319-25.
-
(1994)
Prevention of Venous Thromboembolism
, pp. 319-325
-
-
Clement, D.I.1
Gheeraaerr, P.2
De Buyzere, M.3
Duproz, M.4
-
3
-
-
0026673155
-
Risk of and prophylaxis for venous thromboembolism in hospital patients
-
Thromboembolic risk factors (THRIFT) consensus group. Risk of and prophylaxis for venous thromboembolism in hospital patients. B M J 1992; 305: 567-73.
-
(1992)
B M J
, vol.305
, pp. 567-573
-
-
-
4
-
-
0028856171
-
Prevention of venous thromboembolism. Fourth ACCP Consensus Conference on Antithrombotic Therapy
-
Clagett GP, Anderson FA, Heit J, Levine MN, Brownell Wheeler H. Prevention of venous thromboembolism. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest 1995; 108: S312-S334.
-
(1995)
Chest
, vol.108
-
-
Clagett, G.P.1
Anderson, F.A.2
Heit, J.3
Levine, M.N.4
Brownell Wheeler, H.5
-
5
-
-
0017341166
-
Preventing thromboembolism after myocardial Infarction: Effect of low-dose heparin on smoking
-
Emerson PA, Marks P. Preventing thromboembolism after myocardial Infarction: effect of low-dose heparin on smoking. B M J 1977; 1: 18-20.
-
(1977)
B M J
, vol.1
, pp. 18-20
-
-
Emerson, P.A.1
Marks, P.2
-
6
-
-
0025254642
-
A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep vein thrombosis in acute ischemic stroke
-
Sandset PM, Dahl T, Stiris M et al. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep vein thrombosis in acute ischemic stroke. Semin Thromb Hemost 1990; 16 (suppl): 25-33.
-
(1990)
Semin Thromb Hemost
, vol.16
, Issue.SUPPL.
, pp. 25-33
-
-
Sandset, P.M.1
Dahl, T.2
Stiris, M.3
-
7
-
-
0020157673
-
High risk of the critically ill for venous thromboembolism
-
Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10: 448-50.
-
(1982)
Crit Care Med
, vol.10
, pp. 448-450
-
-
Cade, J.F.1
-
8
-
-
0029869085
-
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
-
Gardlund B and the Swedish Heparin Prophylaxis Study Group. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet 1996; 347: 1357-61.
-
(1996)
Lancet
, vol.347
, pp. 1357-1361
-
-
Gardlund, B.1
-
9
-
-
0029884813
-
Heparin prophylaxis in bedridden patients
-
Bergmann JF, Caulin C. Heparin prophylaxis in bedridden patients. Lancet 1996; 348: 205-6.
-
(1996)
Lancet
, vol.348
, pp. 205-206
-
-
Bergmann, J.F.1
Caulin, C.2
-
10
-
-
0030009099
-
Prevention and treatment of venous thromboembolism
-
Pineo GF, Hull RD. Prevention and treatment of venous thromboembolism. Drugs 1996; 52: 71-92.
-
(1996)
Drugs
, vol.52
, pp. 71-92
-
-
Pineo, G.F.1
Hull, R.D.2
-
11
-
-
0006243571
-
Prevention de la thrombose veineuse en milieu medical: Plaidoyer pour dos exists cliniques qui font cruellement defaut
-
Bergmann JF. Prevention de la thrombose veineuse en milieu medical: plaidoyer pour dos exists cliniques qui font cruellement defaut, STV 1995; 7, 10: 655-7.
-
(1995)
STV
, vol.7-10
, pp. 655-657
-
-
Bergmann, J.F.1
|